Akebia Therapeutics, Inc. To Present At The Jefferies and Co. 2015 Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, 2015, at 2:00 p.m. Eastern Time. The conference is being held at the Grand Hyatt Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.